Canbridge licenses Chinsese rights to Puma's Nerlynx

Puma Biotechnology Inc. (NASDAQ:PBYI) granted Canbridge Life Sciences Ltd. (Beijing, China) exclusive rights to develop and commercialize cancer

Read the full 181 word article

User Sign In